Literature DB >> 14523812

Pediatric extraadrenal paraganglioma.

Tanya M Tekautz1, Charles B Pratt, Jesse J Jenkins, Sheri L Spunt.   

Abstract

BACKGROUND: Pediatric paraganglioma is rare and extraadrenal paraganglioma has not been characterized in children.
METHODS: The authors reviewed the medical records and pathology samples of children with extraadrenal paraganglioma treated at our institution between December 1978 and September 2000. Clinical presentation, treatment, and outcome were evaluated.
RESULTS: Eight patients (median age, 11.4 years) were identified, 4 were boys and none had a family history of paraganglioma or associated syndromes. Primary tumors arose in the retroperitoneum (n = 3), carotid body (n = 2), jugulotympanic ganglion (n = 1), cervical-paraspinal region (n = 1), and lung (n = 1). Extraadrenal paraganglioma had not been suspected at presentation in any patient. Of 5 patients who underwent gross total resection at the time of diagnosis, 4 remain disease free, 1 had microscopic residual tumor and died of disease. Three patients had initially unresectable disease, 2 are disease free after neoadjuvant therapy and delayed surgery, and 1 has persistent disease after tumor embolization and radiotherapy.
CONCLUSIONS: Pediatric extraadrenal paraganglioma occurs most commonly in the retroperitoneum and head and neck, and the diagnosis usually is not suspected at the time of presentation. Surgery is the mainstay of treatment, and outcome is good after gross total resection. Neoadjuvant therapy can facilitate complete resection of initially unresectable tumors.

Entities:  

Mesh:

Year:  2003        PMID: 14523812     DOI: 10.1016/s0022-3468(03)00388-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Ex vivo liver surgery for extraadrenal pheochromocytoma.

Authors:  G Fusai; R Steinberg; A Prachalias; N D Heaton; L Spitz; M Rela
Journal:  Pediatr Surg Int       Date:  2005-11-22       Impact factor: 1.827

2.  The value of pre-operative embolisation in primary inferior vena cava paraganglioma.

Authors:  Faizah Mohd Zaki; Syazarina Sharis Osman; Zaleha Abdul Manaf; Jeyaledchumy Mahadevan; Mazri Yahya
Journal:  Malays J Med Sci       Date:  2011-04

3.  The presentation and management of multiple paraganglioma in head and neck.

Authors:  B G Fennessy; H P W Kozakewich; M Silvera; K Frerichs; C W Lillhei; D Poe; R Rahbar
Journal:  Ir J Med Sci       Date:  2009-05-07       Impact factor: 1.568

4.  Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus "multi-manner" apheresis.

Authors:  M Todorovic; B Balint; N Suvajdzic; M Jevtic; M Pavlovic; M Petrovic; M Krstic; V Popovic; B Ivanovic; I Elezovic; R Milenkovic; M Colovic
Journal:  Med Oncol       Date:  2007-09-25       Impact factor: 3.064

5.  Congenital or acquired Horner's?

Authors:  Ketki Toprani; Shashikant Shetty; P Vijayalakshmi
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.